Загрузка...
Is insulin-like growth factor-1 involved in Parkinson’s disease development?
Parkinson’s disease (PD) is a neurodegenerative disorder that results in the death of dopaminergic neurons within the substantia nigra pars compacta and the reduction in dopaminergic control over striatal output neurons, leading to a movement disorder most commonly characterized by akinesia or brady...
Сохранить в:
| Опубликовано в: : | J Transl Med |
|---|---|
| Главные авторы: | , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BioMed Central
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7014772/ https://ncbi.nlm.nih.gov/pubmed/32046737 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12967-020-02223-0 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|